Status:
UNKNOWN
Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without Oral Non-Narcotic Medications
Lead Sponsor:
Data Collection Analysis Business Management
Conditions:
Pain, Chronic
Pain, Joint
Eligibility:
All Genders
18-64 years
Brief Summary
purpose of this study is to evaluate the level of pain perceived by patients using a transdermal cream and/or transdermal patch with or without an oral medication as a pain management solution.
Detailed Description
The purpose of this minimal risk, observational study is to observe and document patients' perspective on how the combination of transdermal cream and/or transdermal patch(s) with or without oral medi...
Eligibility Criteria
Inclusion
- Participants must be diagnosed with an ICD10 code indicative of chronic pain
- Participants must be starting a new regimen of topical therapy with or without non-narcotic oral medication that has been deemed medically necessary and is independent of the study
- Participants must be expecting to receive therapy for at least 12 weeks
- Participants must be between 18 and 64 years of age
- Participants must be able to provide sound verbal informed consent
Exclusion
- Participants must not be a beneficiary of government funded healthcare program (i.e. Medicare, Medicaid, etc.)
- Participants must not have a diagnosis of cancer within the past 5 years
- Participants who have chronic pain conditions not expected to respond to topical pain medication such as deep abdominal pain, or from conditions such as cancer
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03768011
Start Date
December 1 2018
End Date
June 30 2022
Last Update
December 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DCABM
Land O' Lakes, Florida, United States, 33558